Clinical Edge Journal Scan

Curative resection with endoscopic submucosal dissection of gastric lesions ≥5 cm: To what degree?


 

Key clinical point: In patients with early gastric cancer or gastric adenoma, the curative resection rate with endoscopic submucosal dissection (ESD) for lesions sized ≥5 cm is approximately two-thirds of that for lesions <5 cm; however, delayed perforation is more common in the former.

Major finding: In patients with ≥5 and <5 cm lesions, the curative resection rates were 65.6% and 91.5%, respectively, with the rate of delayed perforation being significantly higher in the former (1.6% and 0.1%, respectively; P = .019).

Study details: This multicenter retrospective study included 3410 ESD-treated gastric lesions in patients aged ≥20 years with early gastric cancer or gastric adenoma and categorized them according to lesion size: <5 cm (n = 3282) and ≥5 cm (n = 128).

Disclosures: This study received no external funding. The authors declared no conflicts of interest.

Source: Chiba H et al. The feasibility and safety of endoscopic submucosal dissection of gastric lesions larger than 5 cm. Gastric Cancer. 2022 (Jul 25). Doi: 10.1007/s10120-022-01323-8

Recommended Reading

Commentary: Treating Gastric Cancer Subtypes, August 2022
MDedge Hematology and Oncology
Treatment combo shows ‘clinical benefit’ in liver cancer trial
MDedge Hematology and Oncology
Patient CRC screening preferences don’t match what they’re being offered
MDedge Hematology and Oncology
New blood test could reshape early CRC screening
MDedge Hematology and Oncology
Getting cancer research on track again may require a ‘behemoth’ effort
MDedge Hematology and Oncology
Lung adverse effects in patients taking trastuzumab deruxtecan
MDedge Hematology and Oncology
Locally advanced gastric cancer: Laparoscopic vs open distal gastrectomy achieves better long-term outcomes
MDedge Hematology and Oncology
Endoscopic resection could replace gastrectomy as the standard treatment for early gastric cancer
MDedge Hematology and Oncology
Locally advanced gastric cancer: Radical surgery yields improved RFS when combined with hyperthermic intraperitoneal chemotherapy
MDedge Hematology and Oncology
Locally advanced gastric cancer: Radical surgery yields improved RFS when combined with hyperthermic intraperitoneal chemotherapy
MDedge Hematology and Oncology